Skip to main content
Cognetivity Neurosciences Ltd. logo

Cognetivity Neurosciences Ltd. — Investor Relations & Filings

Ticker · CGNSF LEI · 529900RVBQDCOD7VZN92 CSE Professional, scientific and technical activities
Filings indexed 154 across all filing types
Latest filing 2023-12-30 Regulatory Filings
Country CA Canada
Listing CSE CGNSF

About Cognetivity Neurosciences Ltd.

http://cognetivity.com

Cognetivity Neurosciences Ltd. is a medical technology company developing an Artificial Intelligence (AI) powered platform for brain health screening and monitoring. Its core product is the Integrated Cognitive Assessment (ICA), also known as the CognICA™ platform. This cognitive testing platform is designed for the early detection of cognitive impairment, including conditions such as Alzheimer's disease and dementia. The platform provides rapid, objective assessment and monitoring of cognitive performance, successfully utilized in clinical settings, including monitoring patients receiving disease-modifying therapy. The technology is deployed across medical, commercial, and consumer environments.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-12-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-12-30 English
Interim MD&A - English.pdf
Regulatory Filings
2023-12-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-12-30 English
News release - English.pdf
Regulatory Filings
2023-11-24 English
News release - English.pdf
Regulatory Filings
2023-10-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.